Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling
<p>Abstract</p> <p>Background</p> <p>Prostate cancer is a leading cause of male cancer specific mortality. When cure by radical prostatectomy is not possible the next line of prostate cancer treatment is androgen deprivation. However prolonged androgen deprivation often...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-03-01
|
Series: | Cancer Cell International |
Online Access: | http://www.cancerci.com/content/8/1/3 |